BDX vs HIND · P/E 34, rev $21.84B vs rev $58.5K
Becton Dickinson and Company (BDX) versus Vyome Holdings, Inc. (HIND) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported HIND revenue for 2026-06-30 was $58.5K. Net income was -$1.6M. Revenue was up 85.3% from 2026-03-31 to 2026-06-30. HIND currently screens at market cap $16.1M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. HIND currently screens at market cap $16.1M.
Not investment advice. Open the BDX and HIND stock pages for the full models.
Not investment advice.